Lupin Launches Generic Hypertension Drug in US
New Delhi: Drug maker Lupin has launched its Amlodipine and Valsartan tablets, used for treatment of hypertension, in the US market after getting approval from the US Food and Drug Administration (FDA).
The US arm of the company, Lupin Pharmaceuticals Inc, has launched Amlodipine and Valsartan tablets in various strengths in the US market after getting final approval from the American health regulator, Lupin said in a statement.
Lupin's Amlodipine and Valsartan tablets are indicated for the treatment of hypertension and to lower blood pressure and is the generic version of Novarts Pharmaceuticals Corporation's Exforge tablets.
As per IMS MAT sales data, Exforge tablets had US sales of $414.9 million.
With this approval, the Mumbai-based firm has received six abbreviated new drug approvals (ANDAs) in the last three months.
Shares in Lupin, on Wednesday, ended at Rs 2038.30 apiece on the BSE, up 1.56 per cent from the previous close.
